A French pharmaceutical giant has slashed the price of a critically important antibiotic used to prevent tuberculosis, giving new hope of beating the disease to millions of people – including hundreds of thousands living with HIV.
The cost of the drug, rifapentine, will be cut from U.S. $45 to $15 dollars for a recommended three-month course of treatment in 100 nations – including 48 in Africa – where TB is a big killer.
The discount deal was negotiated with the pharmaceutical company, Sanofi, by Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria, two initiatives which mobilise resources and finance to fight threats to public health.
Lelio Marmora, head of Unitaid, said the lifesaving drug has, until now, been completely unaffordable in developing countries. “This agreement will help transform political commitment to tangible action,” he added.
Scientists quoted by AFP said the discount will be crucial to the United Nations aim of eradicating the disease by 2030.
The World Health Organisation says an estimated 1.7 billion people, a quarter of the world’s population, are infected by “latent” TB – they are infected but have no symptoms and are not contagious.
Rifapentine, in combination with other medication, stops the infection from developing and being passed to others.
The announcement of the deal said that without treatment, five to 10% of those with latent TB would develop active TB. And those infected by HIV are up to 37 times more likely to do so.
Dr Tereza Kasaeva, director of WHO’s Global TB Programme, called the discount deal a “significant development”, adding that “efforts to make medicines more affordable and patient-friendly will facilitate national TB and HIV programmes quicken their pace to scale up preventive treatment services.”
The discount will have a significant impact on South Africa, which has high rates of TB infection and where many patients living with HIV/Aids die of TB.
South African Minister of Health, Dr. Zweli Mkhize said that “hundreds of thousands of vulnerable people can be initiated on this new treatment regimen starting next year, thanks to this price agreement.”
However, 12 civil society and community-based organizations across the world, while welcoming the development as a step forward, voiced reservations.
“We’re concerned that only 100 countries are eligible and that this is a discount rather than a true new lower ceiling price for all countries,” said Mike Frick of the Treatment Action Group, one of the 12 organisations.
The fact that rifapentine is unregistered in most high-TB-burden countries will be “a major impediment to access,” he added.
“And we eagerly anticipate the entry of generic manufacturers of rifapentine and expect that they will enter the market at a price lower than the $15/patient-course discount granted by Sanofi.”
- Former NSMQ contestant, Francis Tetteh reported dead
- 13 reasons behind Akuapem Poloo’s sentencing
- NDC suspects doctoring of Techiman South election summary sheets
- Mahama must call sycophantic campaigners to order – Kunbuor
- Kuami Eugene reacts after KiDi said his communication is poor
- We’re running into a credibility problem – Kunbour on unanswered calls for NDC’s election 2020 collated figures
- Stolen ring causes teenager’s finger to rot at Pantang
- ECG releases ‘dumsor’ timetable; outages to begin May 10
- Kuami Eugene describes critics of his attire during Range Rover presentation as shallow
- ECG to announce ‘dumsor’ timetable for works on Pokuase BSP
Oil marketing sector risk collapse over market saturation, unhealthy practices – Oil marketing companies
Re: Linda Dor highway rest stop allays fears of commuters
Ed Woodward resigns from Manchester United role
Kotoko to pay Maxwell Konadu $41,000 for breach of contract
Ghana’s CEOs Summit to push for Digital Economy Act
ECG releases ‘dumsor’ timetable; outages to begin May 10
Choosing Alan or Bawumia as 2024 flagbearer may not augur well for NPP – Ben Ephson
Worawora Government Hospital appeal to residents to donate blood
Cadre’s influence in NDC dwindling – Ben Ephson
Sibi residents in Oti Region call on government for access to potable water
People of Shiari calls on government for development facelift
BoG implements policies to accelerate digital financial inclusion
Man City withdraw from Super League; Chelsea set to follow
Teacher allegedly butchers man in Bono Region
Amasaman MP makes donation to Muslims to mark Ramadan celebration